Cargando…
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up
Primary mediastinal large B-cell lymphoma (PMBCL) is a rare and distinct subtype of diffuse large B-cell lymphoma (DLBCL) without prognostic factors or a single standard of treatment clearly defined. In this study we performed retrospective analysis for clinical outcomes of 166 patients with PMBCL....
Autores principales: | Zhou, Hui, Xu-Monette, Zijun Y., Xiao, Ling, Strati, Paolo, Hagemeister, Fredrick B., He, Yizi, Chen, Huan, Li, Yajun, Manyam, Ganiraju C., Li, Yong, Montes-Moreno, Santiago, Piris, Miguel A., Young, Ken H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198569/ https://www.ncbi.nlm.nih.gov/pubmed/32366834 http://dx.doi.org/10.1038/s41408-020-0312-7 |
Ejemplares similares
-
PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma
por: Steiner, Raphael E., et al.
Publicado: (2023) -
Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
por: Chen, Huan, et al.
Publicado: (2021) -
Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations
por: Visco, Carlo, et al.
Publicado: (2017) -
Bendamustine in the treatment of non-Hodgkin’s lymphomas
por: Hagemeister, Fredrick, et al.
Publicado: (2009) -
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
por: Chen, Jiayu, et al.
Publicado: (2015)